A drug commonly used to treat high blood pressure shows promise as a treatment in mouse models of Marfan syndrome and muscular dystrophy (pages 204–210).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Cohn, R.D. et al. Nat. Med. 13, 204–210 (2007).
Collins, C.A. et al. Cell 122, 289–301 (2005).
Olson, E.N., Sternberg, E., Hu, J.S., Spizz, G. & Wilcox, C. J. Cell Biol. 103, 1799–1805 (1986).
Habashi, J.P. et al. Science 312, 117–121 (2006).
Ng, C.M. et al. J. Clin. Invest. 114, 1586–1592 (2004).
Emery, A.E. & Muntoni, F. Duchenne Muscular Dystrophy (Oxford Univ. Press, Oxford, 2003).
Gosselin, L.E. et al. Muscle Nerve 30, 645–653 (2004).
Naito, T. et al. Am. J. Physiol. Renal Physiol. 286, F278–F287 (2004).
Zhou, Y., Poczatek, M.H., Berecek, K.H. & Murphy-Ullrich, J.E. Biochem. Biophys. Res. Commun. 339, 633–641 (2006).
Cohn, R.D. et al. Cell 110, 639–648 (2002).
Webster, C. & Blau, H.M. Somat. Cell Mol. Genet. 16, 557–565 (1990).
Cooper, B.J. et al. Nature 334, 154–156 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chamberlain, J. ACE inhibitor bulks up muscle. Nat Med 13, 125–126 (2007). https://doi.org/10.1038/nm0207-125
Issue Date:
DOI: https://doi.org/10.1038/nm0207-125
This article is cited by
-
Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review
Drugs (2019)
-
Treatment of dystrophin cardiomyopathies
Nature Reviews Cardiology (2014)